# GRIP2

## Overview
The GRIP2 gene encodes the glutamate receptor interacting protein 2, a scaffolding protein primarily involved in synaptic signaling within the central nervous system. This protein is characterized by its seven PDZ domains, which facilitate interactions with various synaptic proteins, including AMPA receptors, thereby playing a crucial role in receptor trafficking and synaptic plasticity (Wyszynski1999Association). GRIP2 is a splice variant of the ABP gene and shares significant structural similarity with GRIP1, particularly in its PDZ domains (Wyszynski1999Association). The protein is predominantly expressed in the brain but is also found in other tissues such as the heart, liver, and testis (Wyszynski1999Association). Alterations in GRIP2 expression have been linked to neurological disorders, highlighting its importance in maintaining synaptic integrity and function (Kouroupi2017Defective).

## Structure
The GRIP2 protein, also known as ABP-L/GRIP2, is a scaffolding protein involved in synaptic signaling, particularly in the anchoring of AMPA receptors. The primary structure of GRIP2 includes 1002 amino acids and is characterized by the presence of seven PDZ domains, which are crucial for protein-protein interactions (Wyszynski1999Association). These PDZ domains facilitate the binding of GRIP2 to AMPA receptors and other synaptic proteins, playing a significant role in synaptic signaling (Wyszynski1999Association).

GRIP2 is a splice variant of the ABP gene, with an N-terminal extension of 52 amino acids and a C-terminal extension that includes an additional seventh PDZ domain compared to ABP (Wyszynski1999Association). The protein is 56% identical and 68% similar to GRIP1, with the greatest similarity in the PDZ domains, particularly PDZ6 and PDZ3 (Wyszynski1999Association).

The secondary, tertiary, and quaternary structures of GRIP2 are not detailed in the available literature. However, the presence of multiple PDZ domains suggests a modular structure that facilitates diverse protein interactions. The protein's expression is predominantly in the brain, with transcripts also found in the heart, liver, and testis (Wyszynski1999Association).

## Clinical Significance
Mutations and alterations in the expression of the GRIP2 gene have been implicated in various neurological disorders. In the context of familial Parkinson's disease (PD), neurons derived from patients with the p.A53T mutation exhibit significant down-regulation of the GRIP2 gene. This down-regulation is associated with synaptic defects, suggesting a disruption in synapse formation and function in PD neurons. The study also notes that some of the altered genes in PD neurons are linked to psychiatric diseases such as autism, schizophrenia, and bipolar disorder, where synaptic dysfunction is a prominent feature (Kouroupi2017Defective).

GRIP2 is also involved in receptor trafficking and localization in neurons, interacting with AMPARs. The palmitoylation of GRIP2b, a splice form of GRIP2, affects its localization to dendritic spines, influencing spine number and size. Although the specific role of GRIP2 in neurodevelopmental and neuropsychiatric conditions is not detailed, the loss of enzymes regulating its palmitoylation, such as DHHC5 or DHHC8, leads to behavioral impairments in mice and is linked to these conditions in humans (Thomas2013Palmitoylationdependent). These findings suggest that GRIP2 plays a critical role in maintaining synaptic integrity and that its dysregulation may contribute to the pathophysiology of several neurological disorders.

## Interactions
GRIP2, a homologous protein to GRIP1, is involved in several interactions crucial for AMPA receptor trafficking and synaptic plasticity. GRIP2 binds to the C-termini of AMPA receptor subunits GluA2 and GluA3, playing a role in their synaptic targeting and recycling (Mao2010GRIP1). It is part of a complex network of interactions with various signaling and cytoskeletal proteins, including the EphB receptor tyrosine kinase, ephrinB ligands, α-liprin scaffolding protein, and kinesin-1/KIF5 microtubule motor protein. These interactions suggest that GRIP2 helps organize macromolecular complexes linking AMPA receptors to the cytoskeleton and membrane trafficking pathways (Mao2010GRIP1).

GRIP2 is also involved in activity-dependent AMPA receptor recycling, mediated by interactions with the exocyst protein complex. Disruption of these interactions impairs AMPA receptor recycling, highlighting the importance of GRIP2 in receptor trafficking (Mao2010GRIP1). Additionally, GRIP2 is found in both excitatory and inhibitory synapses, indicating its role in diverse synaptic functions beyond just anchoring AMPA receptors (Wyszynski1999Association). These interactions underscore GRIP2's role in maintaining synaptic function and plasticity.


## References


[1. (Mao2010GRIP1) Lifang Mao, Kogo Takamiya, Gareth Thomas, Da-Ting Lin, and Richard L. Huganir. Grip1 and 2 regulate activity-dependent ampa receptor recycling via exocyst complex interactions. Proceedings of the National Academy of Sciences, 107(44):19038–19043, October 2010. URL: http://dx.doi.org/10.1073/pnas.1013494107, doi:10.1073/pnas.1013494107. This article has 62 citations.](https://doi.org/10.1073/pnas.1013494107)

[2. (Wyszynski1999Association) Michael Wyszynski, Juli G. Valtschanoff, Scott Naisbitt, Anthone W. Dunah, Eunjoon Kim, David G. Standaert, Richard Weinberg, and Morgan Sheng. Association of ampa receptors with a subset of glutamate receptor-interacting proteinin vivo. The Journal of Neuroscience, 19(15):6528–6537, August 1999. URL: http://dx.doi.org/10.1523/JNEUROSCI.19-15-06528.1999, doi:10.1523/jneurosci.19-15-06528.1999. This article has 212 citations.](https://doi.org/10.1523/JNEUROSCI.19-15-06528.1999)

[3. (Thomas2013Palmitoylationdependent) Gareth M. Thomas and Richard L. Huganir. Palmitoylation-dependent regulation of glutamate receptors and their pdz domain-containing partners. Biochemical Society Transactions, 41(1):72–78, January 2013. URL: http://dx.doi.org/10.1042/bst20120223, doi:10.1042/bst20120223. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/bst20120223)

[4. (Kouroupi2017Defective) Georgia Kouroupi, Era Taoufik, Ioannis S. Vlachos, Konstantinos Tsioras, Nasia Antoniou, Florentia Papastefanaki, Dafni Chroni-Tzartou, Wolfgang Wrasidlo, Delphine Bohl, Dimitris Stellas, Panagiotis K. Politis, Kostas Vekrellis, Dimitra Papadimitriou, Leonidas Stefanis, Piotr Bregestovski, Artemis G. Hatzigeorgiou, Eliezer Masliah, and Rebecca Matsas. Defective synaptic connectivity and axonal neuropathology in a human ipsc-based model of familial parkinson’s disease. Proceedings of the National Academy of Sciences, April 2017. URL: http://dx.doi.org/10.1073/pnas.1617259114, doi:10.1073/pnas.1617259114. This article has 118 citations.](https://doi.org/10.1073/pnas.1617259114)